Summary
1FME Chart
FMS vs. OFIX: Which Stock Should Value Investors Buy Now?
Investors interested in Medical - Instruments stocks are likely familiar with Fresenius (FMS) and Orthofix (OFIX). But which of these two stocks presents investors with the better value opportunity right now?
FMS Stock Rises as Q2 Earnings Beat Estimates, Revenues Gain Y/Y
Fresenius Medical stock rises as Q2 earnings and revenues top estimates, driven by solid organic growth and expanding margins.
Fresenius Medical Care AG (FMS) Q2 2025 Earnings Call Transcript
Fresenius Medical Care AG (NYSE:FMS ) Q2 2025 Earnings Call August 5, 2025 8:00 AM ET Company Participants s - Corporate Participant o - Corporate Participant P - Corporate Participant Dominik Heger - Executive VP and Head of Investor Relations, Strategic Development & Communications Helen Giza - Chair of Management Board & CEO Martin Fischer - CFO & Member of the Management Board Conference Call Participants David James Adlington - JPMorgan Chase & Co, Research Division Falko Friedrichs - Deutsche Bank AG, Research Division Graham Doyle - UBS Investment Bank, Research Division Hassan Al-Wakeel - Barclays Bank PLC, Research Division Hugo Solvet - BNP Paribas Exane, Research Division James Alexander Stewart Vane- Tempest - Jefferies LLC, Research Division Oliver Metzger - ODDO BHF Corporate & Markets, Research Division Richard Felton - Goldman Sachs Group, Inc., Research Division Veronika Dubajova - Citigroup Inc., Research Division a divi - Unidentified Company ion - Unidentified Company f S& - Global Inc. All Rights reserved. Operator Ladies and gentlemen, welcome to the Report on Second Quarter 2025 Conference Call.
Fresenius Medical Care AG & Co. KGaA Dividends
 FMS In 9 months Estimated | Annual | $0.79 Per Share |
| FMS 2 months ago Paid | Annual | $0.79 Per Share |
| FMS 17 May 2024 Paid | Annual | $0.63 Per Share |
| FMS 17 May 2023 Paid | Annual | $0.62 Per Share |
| FMS 13 May 2022 Paid | Annual | $0.71 Per Share |
| FMS 24 May 2021 Paid | Annual | $0.83 Per Share |
Fresenius Medical Care AG & Co. KGaA Earnings
| 4 Nov 2025 (In 2 months) Date | | 0.59 Cons. EPS | - EPS |
| 4 Nov 2025 (In 2 months) Date | | 0.59 Cons. EPS | - EPS |
| 5 Aug 2025 Date | | 0.5 Cons. EPS | 0.46 EPS |
| 29 Jul 2025 Date | | 0.5 Cons. EPS | - EPS |
| 5 May 2025 Date | | 0.38 Cons. EPS | 0.42 EPS |
| FMS In 9 months Estimated | Annual | $0.79 Per Share |
| FMS 2 months ago Paid | Annual | $0.79 Per Share |
| FMS 17 May 2024 Paid | Annual | $0.63 Per Share |
| FMS 17 May 2023 Paid | Annual | $0.62 Per Share |
| FMS 13 May 2022 Paid | Annual | $0.71 Per Share |
| FMS 24 May 2021 Paid | Annual | $0.83 Per Share |
| 4 Nov 2025 (In 2 months) Date | | 0.59 Cons. EPS | - EPS |
| 4 Nov 2025 (In 2 months) Date | | 0.59 Cons. EPS | - EPS |
| 5 Aug 2025 Date | | 0.5 Cons. EPS | 0.46 EPS |
| 29 Jul 2025 Date | | 0.5 Cons. EPS | - EPS |
| 5 May 2025 Date | | 0.38 Cons. EPS | 0.42 EPS |
Fresenius Medical Care AG & Co. KGaA (1FME) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
What is the earnings per share?
When is the next earnings date?
Has Fresenius Medical Care AG & Co. KGaA ever had a stock split?
Fresenius Medical Care AG & Co. KGaA Profile
| Medical - Care Facilities Industry | Healthcare Sector | Helen Giza CEO | XMIL Exchange | US3580291066 ISIN |
| DE Country | 112,035 Employees | 23 May 2025 Last Dividend | 4 Dec 2012 Last Split | - IPO Date |
Overview
Fresenius Medical Care AG is a leading global provider in the field of dialysis and related services, catered towards individuals suffering from renal diseases. Established in 1996 and headquartered in Bad Homburg, Germany, the company has a broad reach extending across Germany, North America, and other international locations. Fresenius Medical Care AG specializes in delivering dialysis treatment and associated laboratory and diagnostic services mainly through its extensive network of outpatient dialysis clinics. Additionally, the company holds contracts with hospitals in the United States to offer dialysis services to hospitalized end-stage renal disease (ESRD) patients and those facing acute kidney failure. Beyond its core services, Fresenius Medical Care AG is engaged in the development, manufacture, and distribution of a wide range of health care products, as well as in the development and licensing of renal pharmaceuticals. It serves a diverse clientele, including dialysis clinics, hospitals, and specialized treatment facilities, through direct sales and a blend of local sales forces, independent distributors, dealers, and sales agents.
Products and Services
Fresenius Medical Care AG provides a comprehensive suite of products and services tailored to meet the needs of renal disease patients and health care providers:
- Dialysis Services and Support: The company delivers dialysis treatment alongside laboratory and diagnostic services through its outpatient clinics. It also provides training, clinical monitoring, follow-up assistance, and home delivery of supplies for patients, alongside contracted dialysis services for hospitalized patients.
- Health Care Products: The product line includes items such as polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, solutions, and granulates. These are essential for performing dialysis treatment both in clinics and at home.
- Renal Pharmaceuticals: Fresenius Medical Care AG works on the development, acquisition, and in-licensing of renal pharmaceuticals. The company also supplies renal medications directly to patients' homes or dialysis clinics, ensuring that those undergoing treatment have easy access to their necessary medications.
- Water Treatment Systems and Other Supplies: The comprehensive list of supplies includes bloodlines, hemodialysis concentrates, peritoneal dialysis solutions, and systems for water treatment, which ensure the safe conduct of dialysis treatment by managing the cleanliness and purity of water used.
- Cardiopulmonary and Apheresis Products: Beyond renal care, the company also offers products for acute cardiopulmonary support and apheresis procedures, addressing the needs of patients with cardiovascular issues or those requiring blood purification.
- Specialized Medical Services: Fresenius Medical Care AG provides additional specialized services, such as vascular, cardiovascular, and endovascular specialty services, ambulatory surgery center management for vascular care, and professional services for nephrology and cardiology. These are intended to complement the core dialysis services by addressing the broader health needs of renal disease patients.
Contact Information
